Debio

Related by string. * * Debio RP . advance Debio *

Related by context. All words. (Click for frequent words.) 70 AEG# 70 XmAb# 70 MEK inhibitor 70 histone deacetylase HDAC inhibitor 69 Hsp# inhibitor 69 BAY #-# 69 orally bioavailable 68 epothilone 68 PXD# 68 BIBW 68 proteasome inhibitor 68 Factor VIIa 67 JAK inhibitor 67 Guanilib 67 CCX# 67 anticancer agent 67 HuMax CD4 67 CUDC 67 polymerase inhibitor 67 vascular disrupting agent 67 Tyrima 66 depsipeptide 66 LY# [003] 66 Dasatinib 66 Nanobody 66 HQK 66 protein kinase inhibitor 66 PDE4 inhibitor 66 HuMax EGFr 66 metaglidasen 66 PI3K inhibitor 66 mertansine 66 Onconase 66 Amrubicin 66 epothilones 66 Tarvacin 66 INCB# [001] 66 humanized monoclonal antibody 66 oral prodrug 66 pan HDAC inhibitor 66 CCR2 65 nucleoside analog 65 ATL# [001] 65 MORAb 65 IAP inhibitors 65 angiogenesis inhibitor 65 HCV protease inhibitor 65 selective inhibitor 65 generation antisense 65 Aplidin 65 PRTX 65 Carfilzomib 65 Xanafide 65 HSP# inhibitor 65 Pathway Inhibitor 65 Azedra 65 Aurora kinase 65 investigational humanized monoclonal antibody 65 Archexin 65 Phenoptin 65 IRX 2 65 IAP inhibitor 64 Zolinza 64 receptor tyrosine kinase inhibitor 64 Panzem 64 INCB# [002] 64 SNT MC# 64 HuLuc# 64 selective inhibition 64 CORT # 64 preclinically 64 novel histone deacetylase 64 cilengitide 64 ISIS # 64 CD# monoclonal antibody 64 Aviptadil 64 PRT# 64 tyrosine kinase inhibitor 64 oral antiviral 64 Insegia 64 VEGF receptor 64 Hsp# inhibitors 64 Bortezomib 64 anticancer agents 64 PLX# 64 MEK inhibitors 64 CCR5 antagonist 64 liposomal formulation 64 Phase 2a trial 64 pertuzumab 64 resolvin 64 anti angiogenic 64 selective androgen receptor modulator 64 Epothilones 64 receptor antagonists 64 AP# [003] 64 R#/MEM # 64 Alpharadin 64 huC# DM4 64 PARP inhibitor 64 systemically administered 64 HCV protease 64 CBLC# 63 enzastaurin 63 tanespimycin 63 TRO# 63 regorafenib 63 SERMs 63 humanized anti 63 reslizumab 63 indibulin 63 thrombopoietin 63 Sym# 63 LY# [002] 63 small molecule Hedgehog 63 RG# [001] 63 HuMax CD# 63 polymerase inhibitors 63 mTOR inhibitors 63 Apaziquone 63 integrase inhibitor 63 RGB # 63 Mipomersen 63 renin inhibitor 63 thymalfasin 63 romidepsin 63 YONDELIS 63 FLT3 63 vorinostat 63 GSK# [001] 63 PS# [001] 63 Tasimelteon 63 antisense drug 63 Preclinical studies suggest 63 Elvitegravir 63 BAL# [002] 63 inhibitor RG# 63 HIV integrase inhibitor 63 rNAPc2 63 Bezielle 63 R#/MEM 63 IMA# 63 CEQ# 63 PCK# 63 Preclinical studies 63 elotuzumab 63 GW# [003] 63 SARMs 63 Symadex 63 zanolimumab 63 phase IIa clinical 63 JAK2 inhibitor 63 ANG# 63 CCR9 antagonist 63 ganetespib 63 AEZS 63 Ceflatonin 63 KSP inhibitor 63 antisense oligonucleotide 63 IMiD 63 kinase inhibitor 63 SRT# [003] 63 vemurafenib 63 CR# vcMMAE 63 prodrug 63 ENMD # 63 2DG 63 immunostimulatory 63 small molecule inhibitor 63 receptor agonist 63 proteasome inhibitors 63 PEG SN# 63 ProMune 63 pomalidomide 63 TYZEKA 63 Kahalalide F 63 orally administered inhibitor 63 histone deacetylase inhibitor 63 anticancer compound 63 Safinamide 63 Proxinium TM 63 OMP #M# 63 XL# XL# 63 OncoVEX GM CSF 62 Bicifadine 62 prucalopride 62 novel peptide 62 microtubule inhibitor 62 MGCD# [001] 62 cetuximab Erbitux R 62 Amplimexon 62 vascular disrupting agents 62 TLR9 agonist 62 CD# antibody [001] 62 bendamustine 62 urocortin 2 62 PEGylated 62 tafamidis 62 Onalta 62 YONDELIS R 62 Campath ® 62 PSN# [002] 62 Phase Ib study 62 Azixa 62 trabectedin 62 CDK inhibitor 62 HspE7 62 Tanespimycin 62 otelixizumab 62 Vilazodone 62 docetaxel Taxotere R 62 HCD# [002] 62 Tamibarotene 62 Maribavir 62 Annamycin 62 Erbitux cetuximab 62 OncoVEX 62 sorafenib Nexavar 62 trastuzumab Herceptin 62 interferon lambda 62 rFIXFc 62 HGS# 62 Kinase Inhibitor 62 cytostatic 62 BMS # 62 TRC# 62 tiapamil 62 Perifosine 62 synthetic siRNA 62 neratinib 62 TLR8 agonist 62 Ceflatonin R 62 UPLYSO 62 MAGE A3 ASCI 62 sodium glucose cotransporter 62 Oncaspar 62 murine monoclonal antibody 62 elacytarabine 62 Triolex 62 RhuDex ® 62 gefitinib Iressa 62 peripherally acting 62 immunomodulator 62 TLR9 agonists 62 Aclidinium 62 ELACYT 62 orally dosed 62 entinostat 62 teduglutide 62 multikinase inhibitor 62 mAb 62 ADI PEG 62 Factor VEGF 62 torezolid 62 PKC# 62 anti angiogenic agent 62 humanized monoclonal 62 eniluracil 62 XL# [003] 62 Hsp# inhibition 62 selective modulator 62 Tavocept 62 tezampanel 62 fosbretabulin 62 somatostatin analogue 62 Tesmilifene 62 Granulocyte Colony Stimulating Factor 62 renin inhibitors 62 retaspimycin hydrochloride 62 decitabine 62 Irinotecan 62 modulator SERM 62 Catena ® 62 TG# [003] 62 forodesine 62 small molecule inhibitors 62 CYC# 62 Sapacitabine 62 ENMD 62 Phase IIa trials 62 antitumor activity 62 APOPTONE 62 potent inhibitor 62 Traficet EN 62 Panzem R 62 JAK1 62 INCB# [003] 62 oncolytic vaccine 61 perifosine 61 protein tyrosine phosphatase 1B 61 nucleoside analogue 61 highly selective inhibitor 61 AKT inhibitor 61 P#X# 61 XYOTAX TM 61 Cethrin 61 NXL# 61 partial agonist 61 IPL# 61 synthetic peptide 61 MKC# MKC# PP 61 SCH # 61 CTAP# Capsules 61 radiolabeled monoclonal antibody 61 favorable pharmacokinetic profile 61 Dapagliflozin 61 HDAC inhibitor 61 INGN 61 VAPRISOL 61 TRV# [001] 61 Nanobody ® 61 BNC# 61 Targretin 61 Nanobodies 61 ruxolitinib 61 JAK inhibitors 61 Hsp# Inhibitor 61 rhMBL 61 Gefitinib 61 investigational compound 61 alpha interferon 61 EGFr 61 Aplidin R 61 HDACi 61 AQ4N 61 nicotinic alpha 7 61 FGFR 61 vidofludimus 61 ONTAK 61 virus HCV protease inhibitor 61 antithrombotic 61 tranilast 61 selective kinase inhibitor 61 pradefovir 61 GSK '# 61 EZN 61 selective antagonist 61 Aflibercept 61 obatoclax 61 HER2 positive metastatic breast 61 NS4A 61 Hycamtin 61 multi kinase inhibitor 61 anti CD3 antibody 61 preclinical efficacy 61 fipamezole 61 ADP receptor antagonist 61 Tarvacin TM 61 small molecule activators 61 cytoprotective 61 Myocet 61 Aurora kinase inhibitor 61 AZX# 61 PLK1 SNALP 61 XmAb 61 dexpramipexole 61 TH# [003] 61 cyclophilin inhibitor 61 glucagon receptor 61 menadione 61 eprotirome 61 Vorinostat 61 TREANDA 61 mitogen activated ERK kinase 61 LEP ETU 61 LB# [003] 61 Pimavanserin 61 ASA# 61 radiation sensitizer 61 diabetic neuropathic pain 61 Alocrest 61 Squalamine 61 ALN TTR 61 CRLX# 61 MT# MEDI 61 Glufosfamide 61 Troxatyl 61 LAF# 61 antitumor 61 Azilect ® 61 VA# [002] 61 SGLT2 61 proteasome inhibitor bortezomib 61 cannabinor 61 PEGylated Fab fragment 61 Tezampanel 61 NVA# 61 chimeric monoclonal antibody 61 novel VDA molecule 61 amifampridine phosphate 61 atacicept 61 FK# 61 budesonide foam 61 AZD# 61 diarrhea predominant irritable 61 immunomodulating 61 volociximab 61 Marqibo TM 61 RH1 61 oral Hsp# inhibitor 61 solithromycin 61 INT# [002] 61 mTOR inhibitor 61 selective agonist 61 dacetuzumab 61 GLYX 61 ONX 61 Vidaza azacitidine 61 rhIL 7 61 PEG Interferon lambda 61 imatinib Gleevec ® 61 dasatinib Sprycel 61 immune modulating 61 OXi# 61 CTCE 61 FTY# 61 NGX# 61 non nucleoside inhibitor 61 EOquin 61 sphingosine 1 61 ozarelix 61 alvespimycin 61 phase IIb clinical 61 Bruton tyrosine kinase Btk 61 alpha folate receptor 61 NNR Therapeutics 61 Panzem R NCD 61 SAR# [002] 61 fluoropyrimidine 61 BAL# [001] 61 Plecanatide 61 relapsing multiple sclerosis 61 TLR8 61 Virulizin ® 61 mu opioid receptor antagonist 61 PrevOnco 61 receptor agonists 61 amrubicin 61 Cloretazine 61 Dalbavancin 61 elvitegravir 60 methylnaltrexone 60 TG# [001] 60 CDP# 60 cinacalcet HCl 60 immunomodulatory 60 EP #R 60 DB# [003] 60 alemtuzumab Campath 60 Cethrin R 60 non nucleoside HCV 60 demethylating agents 60 IgG1 antibody 60 Phase IIa clinical 60 Civacir 60 Pazopanib 60 preclinical studies 60 EpCAM 60 Talabostat 60 cyclin dependent kinase inhibitor 60 LHRH antagonist 60 EGFR tyrosine kinase inhibitors 60 Ophena TM 60 Ixabepilone 60 kinase inhibition 60 MDV# 60 targeting CD# 60 Protexia R 60 ATL/TV# 60 ProSavin 60 GV# [001] 60 Factor Xa inhibitor 60 Maraviroc 60 Crofelemer 60 elesclomol 60 teriflunomide 60 XL# XL# XL# XL# 60 insulin sensitizing 60 brivaracetam 60 Arranon 60 PF # [001] 60 chemically modified siRNA 60 Omacetaxine 60 efaproxiral 60 Bavituximab 60 Aurora Kinase 60 Chrysalin 60 humanized antibody 60 davunetide intranasal AL 60 PDE4 60 Vidofludimus 60 bleomycin 60 Valdoxan 60 Blinatumomab 60 valopicitabine 60 Vaprisol 60 selective inhibitors 60 Epratuzumab 60 TNFa 60 Phase Ib 60 HCV protease inhibitors 60 ZOLINZA 60 targeted antifolate 60 GLP toxicology studies 60 seliciclib 60 talabostat 60 novel anticancer 60 TLR7 60 anti secretory 60 dasatinib Sprycel ® 60 ATL# [002] 60 S#P# 60 axitinib 60 Loramyc R 60 VEGF Trap 60 lexidronam injection 60 PSMA ADC 60 HIV protease inhibitors 60 effector function 60 antibody MAb 60 selective androgen receptor modulators 60 PEGPH# 60 TPI ASM8 60 #I TM# 60 CCR5 mAb 60 ALV# 60 Copegus ribavirin 60 histone deacetylase HDAC 60 Sudhir Agrawal D.Phil 60 BIM #A# 60 anti CD3 60 ORMD 60 kinase inhibitors 60 ADVEXIN 60 L asparaginase 60 Curaxin 60 Amigal 60 ZK EPO 60 Aurexis 60 luteinizing hormone releasing 60 CRx 60 radezolid 60 Ozarelix 60 Cetrorelix 60 potent antiproliferative 60 Varespladib 60 MYDICAR ® 60 AVN# [001] 60 daptomycin 60 CYT# 60 Pharmacokinetics PK 60 Golimumab 60 GRN# 60 PHX# 60 OvaRex ® MAb 60 Sphingomab 60 HDAC Inhibitor 60 Interferon alfa 60 ThermoDox R 60 Daclizumab 60 Pertuzumab 60 synthetic retinoid 60 monoclonal antibody MAb 60 protease inhibitor 60 Lubiprostone 60 RDEA# 60 albinterferon alfa 2b 60 beta 1a 60 TKM ApoB 60 ErbB 60 afamelanotide 60 ZD# [001] 60 interferon beta 1b 60 PTP 1B 60 panitumumab 60 pharmacokinetic profile 60 Fc fusion protein 60 vascular disrupting 60 highly selective adenosine 60 NIC5 60 JAK2 inhibitors 60 Firazyr 60 SPC# [001] 60 baminercept 60 Boceprevir 60 Dacogen decitabine 60 integrase inhibitors 60 Clavis Pharma 60 immune stimulatory 60 ASONEP 60 insulin sensitizer 60 ErbB3 60 Linaclotide 60 interferon IFN 60 ELND# 60 phase Ib 60 pitavastatin 60 vilazodone 60 targeted radiotherapeutic 60 huN# DM1 60 TriRima 60 molecularly targeted 60 SLx 60 tipranavir 60 erlotinib Tarceva ® 60 Synavive 60 KNS # 60 retapamulin 60 masitinib 60 Voreloxin 60 HER3 60 IMiDs 60 apoptotic pathway 60 metastatic renal cell carcinoma 60 gamma secretase inhibitor 60 PEGylated anti 60 Anavex #-# 60 BEMA TM Fentanyl 60 SGLT inhibitors 60 drug zotarolimus 60 INC# 60 Luteinizing Hormone Releasing Hormone 60 HuMax HepC TM 60 Increlex R 60 Aurora kinase inhibitors 60 siRNA therapeutic 60 velafermin 60 BiTE antibody 60 Nexavar sorafenib 60 novel prodrug 60 Increlex ® 60 OMNARIS HFA 59 therapeutic monoclonal antibody 59 pharmacodynamic properties 59 delta isoform 59 echinocandin 59 HGS ETR1 59 pegylated 59 AVONEX ® 59 DP b# 59 Phase 1b 59 ARC# [001] 59 corticosteroid dexamethasone 59 MVA BN 59 ACV1 59 fostamatinib 59 humanised monoclonal antibody 59 GRN#L 59 thalidomide Thalomid 59 PSN# [001] 59 subcutaneous formulation 59 CIMZIA TM 59 TRAIL receptor 59 immune modulatory 59 Leukine ® 59 tipifarnib 59 Hedgehog pathway inhibitor 59 Zoraxel 59 pegfilgrastim 59 DOS# 59 dyskinesia PD LID 59 Fx #A 59 varespladib 59 DEB# 59 PNP inhibitor 59 Vandetanib 59 ospemifene 59 Bafetinib 59 Ganciclovir 59 VQD 59 CA4P 59 adecatumumab 59 epigenetic therapies 59 Liposomal 59 neuroprotective properties 59 immunomodulatory properties 59 prostanoid 59 KB# [002] 59 Eribulin 59 antiangiogenic 59 Radezolid 59 EndoTAG TM -1 59 Loramyc 59 Pralatrexate 59 small molecule tyrosine 59 Ocrelizumab 59 Akt inhibitor 59 Velcade bortezomib 59 PrevOnco ™ 59 RLY# 59 RAPAFLO 59 Desmoteplase 59 selective adenosine 59 PI3K/Akt pathway inhibitor 59 Plicera 59 gastrointestinal stromal tumors GIST 59 nucleotide analog 59 pegylated interferons 59 Phase 2a 59 IMiDs R 59 hormone LHRH antagonist 59 drug ISA# 59 antifibrotic 59 anti EGFR antibody 59 posaconazole 59 Exherin TM 59 CXCR4 59 AZILECT R 59 non nucleoside 59 A3 adenosine receptor 59 chemokine receptor 59 PI3K/mTOR 59 T#I [002] 59 Yondelis ® 59 Phase Ib clinical 59 sargramostim 59 vismodegib 59 immunotherapeutic vaccine 59 zileuton 59 Ophena 59 investigational pan BCR 59 neuroprotectant 59 ProLindac TM 59 quinolone 59 pharmacodynamic PD 59 Temsirolimus 59 peroxisome proliferator activated 59 DXL# 59 EOquin TM 59 Enzastaurin 59 hypoxia inducible factor 59 telomerase therapeutic 59 BRAF inhibitor 59 VitiGam 59 Clusterin 59 chemotherapeutic agent 59 fusion inhibitor 59 Thiovir 59 Janus kinase 59 PDGFR 59 subtype selective 59 NEUGENE antisense 59 PGL# 59 induces apoptosis 59 tubulin inhibitor 59 HIV protease inhibitor 59 Phase Ib II 59 oncolytic virus 59 isoform selective 59 belinostat 59 PARP inhibitors 59 veltuzumab 59 Interferon beta 59 Eg5 59 nitric oxide donating 59 TroVax 59 trodusquemine 59 anticoagulant reversing agent 59 REP# 59 Cloretazine ® 59 Treanda 59 alpha antagonist 59 THR beta agonist 59 agonist 59 NEUGENE 59 ANAVEX #-# [003] 59 glatiramer acetate 59 MGd 59 Monoclonal Antibody 59 tocilizumab 59 Arimoclomol 59 AV HALT 59 SUVN 59 multitargeted 59 EndoTAG 59 receptor modulators 59 LHRH 59 Ridaforolimus 59 IRESSA 59 Nexavar ® 59 pharmacodynamic 59 CD3 monoclonal antibody 59 TAFA# 59 octreotide implant 59 Allovectin 7 R 59 VivaGel TM 59 VEGFR2 59 Clevudine 59 IV Busulfex 59 HepDirect prodrug 59 IFN beta 59 vinca alkaloid 59 Tocilizumab 59 Herceptin trastuzumab 59 Naproxcinod 59 Interferon alpha 59 cell lymphoma CTCL 59 acadesine 59 therapeutic monoclonal antibodies 59 #D#C# 59 antisense inhibitor 59 GPR# [002] 59 DAVANAT 59 TNFα 59 cetuximab Erbitux ® 59 IMiDs ® 59 ceftaroline 59 intranasal formulation 59 Aliskiren 59 RAV# 59 RSD# 59 HIV integrase inhibitors 59 Degarelix 59 eltrombopag 59 NM# [003] 59 IMGN# 59 AEGR 59 CytoFabTM 59 Silodosin 59 S/GSK# 59 oral JAK1 59 ACZ# 59 disease modifying 59 injectable formulation 59 Helsinn 59 Iloperidone 59 TACI Ig 59 SIRT2 59 pain palliation 59 TLR agonists 59 dirucotide 59 Gleevec resistant 59 AtuRNAi 59 MNTX 59 anti TNF 59 ISENTRESS 59 anticancer therapies 59 ANYARA 59 Laquinimod 59 receptor blocker 59 ALN PCS 59 interferon beta 59 PROMACTA 59 MAXY G# 59 CYT# potent vascular disrupting 59 CIMZIA ™ 59 ALN VSP 59 receptor antagonist 59 2 inhibitor CYT# 59 imetelstat 59 antibody fragment 59 Imprime PGG 59 Vfend 59 generation Hsp# inhibitor 59 XL# XL# XL# 59 gastrin 59 CCR5 inhibitor 59 maturation inhibitor 59 erlotinib Tarceva 59 bortezomib Velcade 59 rBChE 59 novel synthetic peptide 59 CRF1 receptor antagonist 59 Cx# [002] 59 5 HT4 59 Triapine 59 Phase 2a Clinical Trial 59 brostallicin 59 PKCi 59 BMS# 59 mecamylamine 59 farletuzumab 59 geldanamycin 59 prostone 59 BZL# 59 Icatibant 59 anti amnesic 59 Argatroban 59 DU #b 59 EGFR inhibitors 59 DFMO 59 PI3 kinase inhibitors 59 peptide conjugated 59 endostatin 59 mapatumumab 59 flavopiridol 59 Pafuramidine 59 BCR ABL inhibitors 59 deacetylase inhibitors 59 antisense inhibitors 59 muscarinic 59 pharmacokinetics pharmacodynamics 59 delafloxacin 59 Phase Ib clinical trials 59 Syncria 59 bardoxolone 59 celgosivir 59 sulodexide 59 Capesaris 59 oncolytic 59 kallikrein 59 histone deacetylase HDAC inhibitors 59 Cerimon 59 Etoposide 59 Olaparib 58 subcutaneously administered 58 selective orally bioavailable 58 long acting muscarinic 58 Romidepsin 58 SB# ONX 58 compound AEZS 58 elvucitabine 58 Alzhemed TM 58 Exelixis XL# 58 rxRNA 58 darunavir 58 FOLOTYN ® 58 pharmacokinetic interactions 58 antagomirs 58 ORENCIA ® 58 lumiliximab 58 Zorbtive TM 58 CGEN # 58 bortezomib Velcade R 58 Hedgehog antagonist 58 HZT 58 fostamatinib disodium 58 Serdaxin 58 trospium 58 nucleoside analogues 58 riociguat 58 Loramyc ® 58 Diamyd ® 58 cediranib 58 Behcet uveitis 58 BXT # 58 PROCHYMAL 58 ulimorelin 58 talactoferrin 58 DPP4 inhibitor 58 LBH# 58 BGC# 58 ProLindac 58 MAXY alpha 58 immunomodulatory therapy 58 imatinib mesylate 58 NU# [001] 58 ARRY # 58 anti proliferative 58 TYKERB 58 PI3K delta 58 ESBA# 58 ON #.Na 58 muraglitazar 58 DORIBAX 58 HGS ETR2 58 Proellex TM 58 Chemokine Receptor 58 Relivar 58 Milatuzumab 58 Angiolix 58 direct thrombin inhibitors 58 bicalutamide 58 antiproliferative activity 58 hematological cancers 58 Receptor Antagonist 58 Elesclomol 58 CTLA 4 58 oral proteasome inhibitor 58 AMN# [001] 58 Pradefovir 58 UVIDEM 58 PRIALT 58 humanized monoclonal antibodies 58 Antiangiogenic 58 ixabepilone 58 Ecallantide 58 RNA antagonist 58 drug conjugate 58 calcineurin inhibitors 58 ToGA 58 Anidulafungin 58 dexamethasone Decadron 58 anticancer therapy 58 Apoptone 58 calcitonin 58 Aptivus ® 58 histone deacetylase inhibitors 58 terlipressin 58 peptibody 58 Avastin bevacizumab 58 Cloretazine R 58 Afatinib 58 antiviral activity 58 vinca alkaloids 58 reversible inhibitor 58 Tarceva TM 58 maribavir 58 PDE7

Back to home page